Endoscopic Treatment of Gastric Adenoma.
10.4166/kjg.2017.70.3.115
- Author:
Cheal Wung HUH
1
;
Byung Wook KIM
Author Information
1. Division of Gastroenterology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea. gastro@catholic.ac.kr
- Publication Type:Review
- Keywords:
Gastric adenoma;
Dysplasia;
Endoscopic treatment
- MeSH:
Adenoma*;
Argon;
Classification;
Plasma;
Stomach Neoplasms
- From:The Korean Journal of Gastroenterology
2017;70(3):115-120
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Gastric adenoma (dysplasia) is a precancerous lesion. Therefore, managements of gastric adenomas are important for preventing the development of gastric cancers and for detecting gastric cancers at earlier stages. The Vienna classification divides gastric adenomas into two categories: high-grade dysplasia and low-grade dysplasia. Generally, endoscopic resection is performed for adenoma with high-grade dysplasia due to the coexistence of carcinoma and the potential of progression to carcinomas. However, the treatments of adenoma with low-grade dysplasia remain controversial. Currently two treatment strategies for the low-grade type have been suggested; First is the ‘wait and see’ strategy; Second is endoscopic treatment (e.g., endoscopic mucosal resection, endoscopic submucosal dissection, or argon plasma coagulation). In this review, we discuss the current optimal strategies for endoscopic management of gastric adenoma.
